ARTA
ANAC

A.R.T. Advisors’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

A.R.T. Advisors’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-38,909
Closed -$4.58M – 1995
2015
Q3 		$4.58M Sell
38,909
-30,331
-44% -$3.96M 0.17% 151
2015
Q2 		$5.36M Sell
69,240
-5,485
-7% -$360K 0.18% 140
2015
Q1 		$4.32M Buy
74,725
+42,566
+132% +$1.81M 0.15% 182
2014
Q4 		$1.04M Sell
32,159
-20,775
-39% -$624K 0.04% 636
2014
Q3 		$1.29M Buy
52,934
+19,591
+59% +$398K 0.06% 432
2014
Q2 		$591K Sell
33,343
-11,141
-25% -$179K 0.03% 705
2014
Q1 		$890K Buy
+44,484
New +$863K 0.05% 539

Other funds holding ANAC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

A.R.T. Advisors's ANAC Position: Q4 2015 in Review

A.R.T. Advisors sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q4 2015, closing a stake of 38,909 shares — an estimated $4.58M sold.

A.R.T. Advisors first reported a position in ANAC in Q1 2014 and held it in 7 quarters. The position peaked at $5.36M in Q2 2015. 214 funds tracked by Wall St. Rank hold ANAC as of Q4 2015.

  • A.R.T. Advisors reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q4 2015 after selling out during the quarter.
  • A.R.T. Advisors sold 38,909 ANACOR PHARMACEUTICALS INC COM shares in Q4 2015, an estimated $4.58M.
  • A.R.T. Advisors first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2014 and held it in 7 quarters.
  • A.R.T. Advisors's ANACOR PHARMACEUTICALS INC COM position peaked at $5.36M in Q2 2015.
  • 214 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q4 2015.

Based on A.R.T. Advisors's 13F filing for Q4 2015, filed 16 Feb 2016.